Enzyme Research
Private Company
Funding information not available
Overview
Enzyme Research Laboratories is a well-established, privately-held specialty reagent company focused exclusively on the coagulation and hemostasis research market. With over 40 years of operational history (incorporating a predecessor entity), ERL has built a trusted reputation for producing high-quality, purified proteins and antibodies critical for foundational research. The company operates on a business-to-business (B2B) model, selling directly to academic, pharmaceutical, and diagnostic laboratories worldwide. Its ISO 9001:2015 certification underscores a commitment to quality and consistency in its manufacturing processes.
Technology Platform
Expertise in large-scale purification of coagulation proteins and antibodies from human and animal plasma. Platform includes production of zymogens, activated enzymes, active-site blocked enzymes, cofactors, inhibitors, and species-specific proteins for research.
Opportunities
Risk Factors
Competitive Landscape
ERL competes in the specialty coagulation reagent market against other niche suppliers and the broader portfolios of large life science conglomerates (e.g., Thermo Fisher, Abcam). Its competitive edge is deep specialization, high purity standards, and a comprehensive product catalog covering the entire coagulation cascade, fostering strong brand loyalty within its focused research community.